With a commitment to innovation, AFT Pharmaceuticals develops, licenses and sells a wide range of products to help improve the health and wellbeing of people.
About AFT Pharmaceuticals.
Read More
Pharmaceuticals
with a difference
Browse latest news
We develop, license, and sell pharmaceutical products in Australasia and around the world. Check out our latest news.
Read More
Our range of innovative products
Learn more about our range of products.
Read More
Kiwis Thinking About Health
Kiwis Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help New Zealanders live a healthier life.
Read More
Aussies Thinking About Health
Aussies Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help Australians live a healthier life.
Read More
Our range of innovative products
Learn more about our range of products
Browse our products
Please select your region below to view products
Our Initiatives
Kiwis Thinking About Health
Kiwis Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help New Zealanders live a healthier life.
Our Initiatives
Aussies Thinking About Health
Aussies Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help Australians live a healthier life.
AFT Pharma reports growth and global expansion
FINANCIAL RESULTS FOR THE SIX MONTHS TO 30 SEPTEMBER 2023
Read More
AFT welcomes US FDA approval for sale of Maxigesic IV®
AFT Pharmaceuticals announces the US FDA has approved Maxigesic IV®, the intravenous form of its patented pain relief medicine, for sale in the US, which represents AFT’s second FDA approval within one year.
Read More
AFT Pharmaceuticals to announce half year interim results
AFT Pharmaceuticals announced today that it intends to release on Thursday November 23 2023 its half year interim results for the period ended September 30 2023.
Read More